Krystal Biotech, Inc. (KRYS) Balance sheet

Market cap

$10.7B

P/E ratio

	2017/12	2019/12	2020/12	2021/12	2022/12	2023/12	2024/12
Cash and cash equivalents	50	188	268	341	162	358	345
Marketable securities, current	-	6	3	97	217	174	253
Total cash & short-term investments	50	194	271	438	379	532	598
Accounts receivable, net	-	-	-	-	-	42	105
Inventories	-	-	-	-	-	7	27
Total current assets	50	196	275	442	384	588	742
Property, plant and equipment, net	0	8	31	112	162	161	155
Marketable securities, non-current	-	0	-	64	5	62	152
Total non-current assets	0	13	36	184	175	230	314
Total assets	50	209	311	626	558	818	1,056
Accounts payable	0	1	2	8	4	4	5
Total current liabilities	1	3	15	26	29	33	102
Total non-current liabilities	-	3	3	7	7	7	7
Total liabilities	1	6	19	33	36	40	109
Common stock and paid-in capital	59	242	363	735	804	1,048	1,127
Retained earnings	-9	-39	-71	-141	-281	-270	-181
Stockholders' equity	49	203	292	594	522	779	946
Working capital	-	-	-	-	-